One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Artificial Intelligence (AI) In Genomics Market

ゲノミクスにおける人工知能市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2025年


[ 英語タイトル ] Artificial Intelligence (AI) In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research)-Global Forecasts to 2025


Product Code : MNMHC00114057
Survey : MarketsandMarkets
Publish On : May, 2021
Number of Pages : 149
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The global AI in genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025. The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

“Machine learning segment is expected to grow at the highest rate during the forecast period”
Based on technology, the AI in genomics market is segmented into machine learning and other technologies. The machine learning segment is projected to register a higher CAGR during the forecast period. The high growth rate of this segment is mainly as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug genomics applications. This is because machine learning can extract insights from data sets, accelerating genomic research.

“Diagnostics segment is estimated to account for the largest share of the AI in genomics market in 2019”
Based on application, the AI in genomics market is segmented into diagnostics, drug discovery &development, precision medicine, agriculture & animal research, and other applications. Diagnostics was the largest application segment in the AI in genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases and the decreasing cost of sequencing.

“North America is expected to dominate the AI in genomics market in 2020”
In 2019, North America accounted for the largest share of the AI in genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US. The market in the Asia Pacific region, on the other hand, is projected to register the highest CAGR during the forecast period. Emerging countries in the APAC, such as India and China, offer lucrative growth opportunities for market players, primarily due to the increasing public and private funding, improving healthcare infrastructure, and rapid economic growth.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (31%), Tier 2(28%), and Tier 3 (41%)
• By Designation: C-level (31%), Director-level (25) and Others (44%)
• By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)

The key players operating in this market include IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK), Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), and Engine Biosciences Pte. Ltd. (US).Product launches, expansions, collaborations, agreements, partnerships, and acquisitions are the key growth strategies followed by a majority of players in this market.

Research Coverage
• The report studies the AI in genomics market based on offering, technology, functionality, application, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in genomics market
• The report forecasts the revenue of market segments with respect to four major regions

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the AI in genomics offered by the key 20 players in the AI in genomics market. The report analyzes the AI in genomics market by offering, technology, functionality, application, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various AI in genomics, their adoption, and usage across key geographic regions.

• Market Diversification: Exhaustive information about new product launches, untapped geographies, recent developments, and investments in the AI in genomics market

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the AI in genomics market.

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
FIGURE 1 ARTIFICIAL INTELLIGENCE IN GENOMICS: MARKET SEGMENTATION 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 25
1.5 LIMITATIONS 25
1.6 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 2 RESEARCH DESIGN 27
2.2 SECONDARY SOURCES 28
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.3 PRIMARY DATA 30
2.3.1 PRIMARY SOURCES 30
2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION 31
2.3.2.1 Key industry insights 31
2.4 MARKET SIZE ESTIMATION 32
FIGURE 1 BOTTOM-UP APPROACH 33
FIGURE 2 TOP-DOWN APPROACH 33
FIGURE 3 ESTIMATION OF THE AI IN GENOMICS MARKET SIZE THROUGH THE ADOPTION-BASED APPROACH 33
TABLE 1 FACTOR ANALYSIS 34
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 35
FIGURE 4 DATA TRIANGULATION METHODOLOGY 35
2.6 ASSUMPTIONS FOR THE STUDY 36
3 EXECUTIVE SUMMARY 37
FIGURE 5 AI IN GENOMICS MARKET, BY OFFERING, 2020 VS. 2025 (USD MILLION) 37
FIGURE 6 AI IN GENOMICS MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION) 38
FIGURE 7 AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2020 VS. 2025 (USD MILLION) 38
FIGURE 8 AI IN GENOMICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 39
FIGURE 9 AI IN GENOMICS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 39
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE AI IN GENOMICS MARKET 40
4 PREMIUM INSIGHTS 41
4.1 AI IN GENOMICS: MARKET OVERVIEW 41
FIGURE 11 INCREASING PUBLIC AND PRIVATE INVESTMENTS IN AI IN GENOMICS AND ADOPTION OF AI SOLUTIONS FOR PRECISION MEDICINE ARE DRIVING MARKET GROWTH 41
4.2 AI IN GENOMICS MARKET, BY END USER 42
FIGURE 12 PROVIDERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019 42
4.3 NORTH AMERICA: AI IN GENOMICS MARKET, BY TECHNOLOGY & COUNTRY (2019) 42
FIGURE 13 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019 42
4.4 GEOGRAPHICAL SNAPSHOT OF THE AI IN GENOMICS MARKET 43
FIGURE 14 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Need to control the time and costs of drug development and discovery 45
5.2.1.2 Increasing investments in AI in genomics 45
5.2.1.3 Rising adoption of AI in precision medicine 46
5.2.1.4 Growing genomic datasets 46
5.2.2 RESTRAINTS 46
5.2.2.1 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Focus on developing human-aware AI systems 47
5.2.4 CHALLENGES 47
5.2.4.1 Lack of curated genomic data 47
5.2.4.2 Data privacy concerns 48
5.3 IMPACT OF COVID-19 ON THE AI IN GENOMICS MARKET 48
FIGURE 15 IMPACT OF COVID-19 ON THE AI IN GENOMICS MARKET 49
5.4 ECOSYSTEM 49
FIGURE 16 AI IN GENOMICS MARKET: ECOSYSTEM 50
6 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING 51
6.1 INTRODUCTION 52
TABLE 2 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 52
6.2 SOFTWARE 52
6.2.1 BENEFITS OFFERED BY SOFTWARE & STRONG DEMAND AMONG END USERS ARE DRIVING MARKET GROWTH 52
TABLE 3 AI IN GENOMICS MARKET FOR SOFTWARE, BY REGION,
2018–2025 (USD MILLION) 53
TABLE 4 NORTH AMERICA: AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION) 53
TABLE 5 EUROPE: AI IN GENOMICS MARKET FOR SOFTWARE, BY COUNTRY,
2018–2025 (USD MILLION) 53
6.3 SERVICES 54
6.3.1 SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 54
TABLE 6 AI IN GENOMICS MARKET FOR SERVICES, BY REGION,
2018–2025 (USD MILLION) 54
TABLE 7 NORTH AMERICA: AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION) 54
TABLE 8 EUROPE: AI IN GENOMICS MARKET FOR SERVICES, BY COUNTRY,
2018–2025 (USD MILLION) 55
7 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY 56
7.1 INTRODUCTION 57
TABLE 9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 57
7.2 MACHINE LEARNING 57
TABLE 10 AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE,
2018–2025 (USD MILLION) 57
TABLE 11 AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY REGION,
2018–2025 (USD MILLION) 58
TABLE 12 NORTH AMERICA: AI IN GENOMICS MARKET FOR MACHINE LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 13 EUROPE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY COUNTRY, 2018–2025 (USD MILLION) 58
7.2.1 DEEP LEARNING 59
7.2.1.1 Deep learning is the fastest-growing and largest subsegment of machine learning 59
TABLE 14 AI IN GENOMICS MARKET FOR DEEP LEARNING, BY REGION,
2018–2025 (USD MILLION) 59
TABLE 15 NORTH AMERICA: AI IN GENOMICS MARKET FOR DEEP LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 16 EUROPE: AI IN GENOMICS MARKET FOR DEEP LEARNING, BY COUNTRY, 2018–2025 (USD MILLION) 60
7.2.2 SUPERVISED LEARNING 60
7.2.2.1 Supervised learning can help create predictive models 60
TABLE 17 AI IN GENOMICS MARKET FOR SUPERVISED LEARNING, BY REGION,
2018–2025 (USD MILLION) 60
TABLE 18 NORTH AMERICA: AI IN GENOMICS MARKET FOR SUPERVISED LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 19 EUROPE: AI IN GENOMICS MARKET FOR SUPERVISED LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 61
7.2.3 REINFORCEMENT LEARNING 61
7.2.3.1 APAC to show the highest growth in the reinforcement learning market 61
TABLE 20 AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2018–2025 (USD MILLION) 62
TABLE 21 NORTH AMERICA: AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2018–2025 (USD MILLION) 62
TABLE 22 EUROPE: AI IN GENOMICS MARKET FOR REINFORCEMENT LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 62
7.2.4 UNSUPERVISED LEARNING 63
7.2.4.1 Unsupervised learning algorithms allow for complex processing tasks, exceeding the capabilities of supervised systems 63
TABLE 23 AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2018–2025 (USD MILLION) 63
TABLE 24 NORTH AMERICA: AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 25 EUROPE: AI IN GENOMICS MARKET FOR UNSUPERVISED LEARNING,
BY COUNTRY, 2018–2025 (USD MILLION) 64
7.2.5 OTHER MACHINE LEARNING TECHNOLOGIES 64
TABLE 26 AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION) 64
TABLE 27 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 65
TABLE 28 EUROPE: AI IN GENOMICS MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION) 65
7.3 OTHER TECHNOLOGIES 65
TABLE 29 AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2018–2025 (USD MILLION) 66
TABLE 30 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2018–2025 (USD MILLION) 66
TABLE 31 EUROPE: AI IN GENOMICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2018–2025 (USD MILLION) 66
8 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY 67
8.1 INTRODUCTION 68
TABLE 32 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION) 68
8.2 GENOME SEQUENCING 68
8.2.1 GENOME SEQUENCING HOLDS THE LARGEST SHARE OF THE MARKET,
BY FUNCTIONALITY 68
TABLE 33 AI IN GENOMICS MARKET FOR GENOME SEQUENCING, BY REGION,
2018–2025 (USD MILLION) 69
TABLE 34 NORTH AMERICA: AI IN GENOMICS MARKET FOR GENOME SEQUENCING,
BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 35 EUROPE: AI IN GENOMICS MARKET FOR GENOME SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION) 69
8.3 GENE EDITING 70
8.3.1 GROWING IMPLEMENTATION OF MACHINE LEARNING IN GENE EDITING MAY HELP REDUCE TIME AND COSTS 70
TABLE 36 AI IN GENOMICS MARKET FOR GENE EDITING, BY REGION,
2018–2025 (USD MILLION) 70
TABLE 37 NORTH AMERICA: AI IN GENOMICS MARKET FOR GENE EDITING,
BY COUNTRY, 2018–2025 (USD MILLION) 70
TABLE 38 EUROPE: AI IN GENOMICS MARKET FOR GENE EDITING, BY COUNTRY,
2018–2025 (USD MILLION) 71
8.4 CLINICAL WORKFLOWS 71
8.4.1 MACHINE LEARNING CAN HELP INCREASE THE EFFICIENCY OF THE CLINICAL WORKFLOW 71
TABLE 39 AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW, BY REGION,
2018–2025 (USD MILLION) 71
TABLE 40 NORTH AMERICA: AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW,
BY COUNTRY, 2018–2025 (USD MILLION) 72
TABLE 41 EUROPE: AI IN GENOMICS MARKET FOR CLINICAL WORKFLOW, BY COUNTRY, 2018–2025 (USD MILLION) 72
8.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE 72
8.5.1 AI IN GENOMICS CAN PREDICT OUTCOMES AND THE RISKS ASSOCIATED IN CURING GENETIC DISEASES, BASED ON THE AVAILABLE DATA 72
TABLE 42 AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018–2025 (USD MILLION) 73
TABLE 43 NORTH AMERICA: AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION) 73
TABLE 44 EUROPE: AI IN GENOMICS MARKET FOR PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION) 73
9 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION 74
9.1 INTRODUCTION 75
TABLE 45 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 75
9.2 DIAGNOSTICS 75
9.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE AI IN GENOMICS MARKET 75
TABLE 46 AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY REGION,
2018–2025 (USD MILLION) 76
TABLE 47 NORTH AMERICA: AI IN GENOMICS MARKET FOR DIAGNOSTICS,
BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 48 EUROPE: AI IN GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2018–2025 (USD MILLION) 76
9.3 DRUG DISCOVERY & DEVELOPMENT 77
9.3.1 GROWING APPLICATION OF AI IN GENOMICS IN DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH 77
TABLE 49 INDICATIVE LIST OF DEVELOPMENTS 77
TABLE 50 AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2018–2025 (USD MILLION) 78
TABLE 51 NORTH AMERICA: AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 52 EUROPE: AI IN GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2018–2025 (USD MILLION) 78
9.4 PRECISION MEDICINE 79
9.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS 79
TABLE 53 INDICATIVE LIST OF DEVELOPMENTS FOR PRECISION MEDICINE APPLICATION 79
TABLE 54 AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY REGION,
2018–2025 (USD MILLION) 79
TABLE 55 NORTH AMERICA: AI IN GENOMICS MARKET FOR PRECISION MEDICINE,
BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 56 EUROPE: AI IN GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY, 2018–2025 (USD MILLION) 80
9.5 AGRICULTURE & ANIMAL RESEARCH 80
9.5.1 AI IN GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK 80
TABLE 57 AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY REGION, 2018–2025 (USD MILLION) 81
TABLE 58 NORTH AMERICA: AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 59 EUROPE: AI IN GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2018–2025 (USD MILLION) 81
9.6 OTHER APPLICATIONS 82
TABLE 60 AI IN GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2018–2025 (USD MILLION) 82
TABLE 61 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 82
TABLE 62 EUROPE: AI IN GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 83
10 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER 84
10.1 INTRODUCTION 85
TABLE 63 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 85
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
10.2.1 RISING DEMAND FOR SOLUTIONS TO CUT TIME AND COSTS OF DRUG DEVELOPMENT HAVE DRAWN END-USER ATTENTION TO AI IN GENOMICS 85
TABLE 64 INDICATIVE LIST OF DEVELOPMENTS 86
TABLE 65 AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 86
TABLE 66 NORTH AMERICA: AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 67 EUROPE: AI IN GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 87
10.3 RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS 87
10.3.1 RISING RESEARCH ACTIVITY TO DRIVE THE USAGE OF AI IN GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES 87
TABLE 68 INDICATIVE LIST OF RESEARCH COLLABORATIONS 87
TABLE 69 AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 88
TABLE 70 NORTH AMERICA: AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 71 EUROPE: AI IN GENOMICS MARKET FOR RESEARCH CENTERS, ACADEMIC INSTITUTES, & GOVERNMENT ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 88
10.4 HEALTHCARE PROVIDERS 89
10.4.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS 89
TABLE 72 AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION,
2018–2025 (USD MILLION) 89
TABLE 73 NORTH AMERICA: AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2018–2025 (USD MILLION) 90
TABLE 74 EUROPE: AI IN GENOMICS MARKET FOR HEALTHCARE PROVIDERS,
BY COUNTRY, 2018–2025 (USD MILLION) 90
10.5 OTHER END USERS 90
TABLE 75 AI IN GENOMICS MARKET FOR OTHER END USERS, BY REGION,
2018–2025 (USD MILLION) 91
TABLE 76 NORTH AMERICA: AI IN GENOMICS MARKET FOR OTHER END USERS,
BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 77 EUROPE: AI IN GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2025 (USD MILLION) 91
11 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION 92
11.1 INTRODUCTION 93
TABLE 78 ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, BY REGION,
2018–2025 (USD MILLION) 93
11.2 NORTH AMERICA 94
FIGURE 17 NORTH AMERICA: AI IN GENOMICS MARKET SNAPSHOT 94
TABLE 79 NORTH AMERICA: AI IN GENOMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 95
TABLE 80 NORTH AMERICA: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 95
TABLE 81 NORTH AMERICA: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 95
TABLE 82 NORTH AMERICA: AI IN GENOMICS MARKET FOR MACHINE LEARNING,
BY TYPE, 2018–2025 (USD MILLION) 96
TABLE 83 NORTH AMERICA: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 96
TABLE 84 NORTH AMERICA: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 96
TABLE 85 NORTH AMERICA: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 97
11.2.1 US 97
11.2.1.1 The US dominates the North American AI in genomics market 97
TABLE 86 US: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS 97
TABLE 87 US: AI IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION) 98
TABLE 88 US: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 98
TABLE 89 US: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE,
2018–2025 (USD MILLION) 98
TABLE 90 US: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 99
TABLE 91 US: AI IN GENOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 99
TABLE 92 US: AI IN GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 99
11.2.2 CANADA 100
11.2.2.1 Increasing research in genomics to drive market growth 100
TABLE 93 CANADA: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 100
TABLE 94 CANADA: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 100
TABLE 95 CANADA: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 96 CANADA: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 101
TABLE 97 CANADA: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 101
TABLE 98 CANADA: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 102
11.3 EUROPE 102
TABLE 99 EUROPE: AI IN GENOMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 102
TABLE 100 EUROPE: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 103
TABLE 101 EUROPE: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 103
TABLE 102 EUROPE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION) 103
TABLE 103 EUROPE: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 104
TABLE 104 EUROPE: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 104
TABLE 105 EUROPE: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 104
11.3.1 UK 105
11.3.1.1 UK to register the highest CAGR in the European market during the forecast period 105
TABLE 106 UK: AI IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION) 105
TABLE 107 UK: AI IN GENOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 106
TABLE 108 UK: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE,
2018–2025 (USD MILLION) 106
TABLE 109 UK: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 106
TABLE 110 UK: AI IN GENOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 107
TABLE 111 UK: AI IN GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 107
11.3.2 GERMANY 107
11.3.2.1 Availability of funding for AI initiatives to boost the market growth in Germany 107
TABLE 112 GERMANY: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 108
TABLE 113 GERMANY: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 108
TABLE 114 GERMANY: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 115 GERMANY: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 109
TABLE 116 GERMANY: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 109
TABLE 117 GERMANY: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 110
11.3.3 FRANCE 110
11.3.3.1 Increasing government investments in genomics to boost the growth of the French market 110
TABLE 118 FRANCE: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 110
TABLE 119 FRANCE: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 111
TABLE 120 FRANCE: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION) 111
TABLE 121 FRANCE: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 111
TABLE 122 FRANCE: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 112
TABLE 123 FRANCE: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 112
11.3.4 ROE 112
TABLE 124 ROE: AI IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION) 113
TABLE 125 ROE: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 113
TABLE 126 ROE: AI IN GENOMICS MARKET FOR MACHINE LEARNING,
BY TYPE, 2018–2025 (USD MILLION) 113
TABLE 127 ROE: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 114
TABLE 128 ROE: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 114
TABLE 129 ROE: AI IN GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 114
11.4 ASIA PACIFIC 115
11.4.1 EFFORTS TO DEVELOP IT INFRASTRUCTURE WILL DRIVE THE MARKET
FOR AI IN THE APAC 115
FIGURE 18 ASIA PACIFIC: AI IN GENOMICS MARKET SNAPSHOT 116
TABLE 130 ASIA PACIFIC: AI IN GENOMICS MARKET, BY OFFERING,
2018–2025 (USD MILLION) 116
TABLE 131 ASIA PACIFIC: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 117
TABLE 132 ASIA PACIFIC: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 133 ASIA PACIFIC: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 117
TABLE 134 ASIA PACIFIC: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 118
TABLE 135 ASIA PACIFIC: AI IN GENOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 118
11.5 ROW 118
TABLE 136 ROW: AI IN GENOMICS MARKET, BY OFFERING, 2018–2025 (USD MILLION) 119
TABLE 137 ROW: AI IN GENOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 119
TABLE 138 ROW: AI IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 139 ROW: AI IN GENOMICS MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 120
TABLE 140 ROW: AI IN GENOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 120
TABLE 141 ROW: AI IN GENOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 121
12 COMPETITIVE LANDSCAPE 122
12.1 OVERVIEW 122
FIGURE 19 KEY DEVELOPMENTS IN THE AI IN GENOMICS MARKET (2018–2020) 122
12.2 AI IN GENOMICS MARKET: RANKING ANALYSIS (2019) 123
FIGURE 20 MARKET RANKING ANALYSIS, 2019 123
12.3 COMPETITIVE SCENARIO (2018–2020) 124
12.3.1 KEY AGREEMENTS, CONTRACTS, AND PARTNERSHIPS (2018–2020) 124
12.3.2 KEY PRODUCT LAUNCHES (2018–2020) 124
12.3.3 KEY EXPANSIONS (2018–2020) 125
12.3.4 KEY ACQUISITIONS (2018–2020) 125
12.4 COMPETITIVE LEADERSHIP MAPPING 125
12.5 VENDOR INCLUSION CRITERIA 125
12.5.1 STARS 125
12.5.2 EMERGING LEADERS 126
12.5.3 PERVASIVE PLAYERS 126
12.5.4 EMERGING COMPANIES 126
FIGURE 21 AI IN GENOMICS: COMPETITIVE LEADERSHIP MAPPING, 2019 126

13 COMPANY PROFILES 127
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 IBM 127
FIGURE 22 IBM: COMPANY SNAPSHOT (2019) 127
13.2 NVIDIA 129
FIGURE 23 NVIDIA: COMPANY SNAPSHOT (2019) 129
13.3 MICROSOFT CORPORATION 131
FIGURE 24 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2020) 131
13.4 DEEP GENOMICS 133
13.5 BENEVOLENTAI 134
13.6 FABRIC GENOMICS 135
13.7 VERGE GENOMICS 136
13.8 FREENOME HOLDINGS 137
13.9 MOLECULARMATCH 138
13.10 CAMBRIDGE CANCER GENOMICS 139
13.11 SOPHIA GENETICS 141
13.12 DATA4CURE 143
13.13 PRECISIONLIFE 144
13.14 GENOOX 145
13.15 LIFEBIT 146
13.16 DIPLOID 147
13.17 FDNA 147
13.18 DNANEXUS 147
13.19 EMPIRIC LOGIC 148
13.20 ENGINE BIOSCIENCES 148
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 149
14.1 DISCUSSION GUIDE 149
14.2 AVAILABLE CUSTOMIZATIONS 153
14.3 RELATED REPORTS 153
14.4 AUTHOR DETAILS 154

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+